by admin | Jul 20, 2023
back to portfolio HoloclaraOur unique discovery engine allows us to identify molecules, derived from worm species, to develop into safe, orally-available therapeutics. Allergic and autoimmune diseases were first described in the early 1900s, the same time that...
by admin | Jul 20, 2023
back to portfolio Immunis BiomedicalChanging the course of immune-related diseases and aging. Immunis is a private biotechnology company researching and developing immune secretome products to address age-driven immune deficits. Immunis has developed a novel method to...
by admin | Jul 20, 2023
back to portfolio MAIA BiotechnologyMAIA Biotechnology, Inc. is a targeted therapy, immune-oncology company, focused on the development of first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people...
by admin | Jul 20, 2023
back to portfolio ReglageneTransforming Tubulin Therapy for Brain Diseases Breaking through the blood-brain barrier with breakthrough treatment. Learn...
by admin | Jul 20, 2023
back to portfolio RegulonixNon-opioid drugs for chronic pain to attack a global health epidemic. Regulonix was founded to address the growing opioid epidemic. Our science approaches the issue of treating pain in an entirely new way that is targeted and highly...
